No plans to expand in other Indian cities: US Pharmacopeia

The United States Pharmacopeial Convention (USP) is ramping up its operations across the world by investing US $200 million in the next 5 years.


A part of this investment will be made in India. It aims to execute multiple activities in the country including medical monograph modernization, increasing resources, building manpower, and expanding technology-related activities.

In 2005, USP opened its first office and collaborative testing laboratory facility outside of the United States, near Hyderabad.

"Since USP India's opening, India's pharmaceutical industry has continued to grow rapidly, resulting in an increased demand for USP standards and services," said Dr K V Surendranath, SVP, International Site Operations, USP-India.

The USP India facility works to create standards for medicines ensuring full safety and quality of medicines, and brining international standards in drug manufacturing to India.

The not-for-profit organization develops reference standards to ensure the quality of Active Pharmaceutical Ingredients (APIs) and supports government's initiatives to strengthen domestic manufacture of intermediaries and APIs.


Previous 1 3 4 5 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email